Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001179110-19-012550

SVP & Chief Medical Officer acquired 8,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Paolini John F. · SVP & Chief Medical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2019-12-05 Exercise or conversion : show line 1 in the form +8,000 $1.86 $14,880 8,000 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-12-05 Exercise or conversion : show line 2 in the form Share Option −8,000 209,574 D
Loading xslF345X03/edgar.xml…